EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anthrax: Transmission, Pathogenesis, Prevention and Treatment

Nitika Sangwan, Aakriti Gangwal, Preksha Jain, Chokey Langtso, Shruti Srivastava, Uma Dhawan iD, Renu Baweja iD, Yogendra Singh iD

Toxins · 24.01.2025 · 17 (2) · 56

DOI: 10.3390/toxins17020056 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 24.01.2025. Verfasst von Nitika Sangwan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Bhaskaracharya College of Applied Sciences, University of Delhi, Delhi 110075, India. Hauptthemen laut MEDLINE: Anthrax, Bacillus anthracis, Anthrax Vaccines. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacillus anthracis is a deadly pathogen that under unfavourable conditions forms highly resistant spores which enable them to survive for a long period of time. Spores of B. anthracis are transmitted through the contaminated soil or animal products and enter to the host through the skin, lungs or oral route and can cause cutaneous, injection, inhalation and gastrointestinal anthrax, respectively. The disease is caused by the toxin which is produced by them once they germinate within the host cell. Anthrax toxin is the major virulence factor which has the ability to kill the host cell. The role of protein kinases and phosphatases of B. anthracis in toxin production and other virulence related properties have also been reported. There are two vaccines, BioThrax and CYFENDUSTM, which are approved by the FDA-USA to prevent anthrax disease. Recently, anthrax toxin has also been shown to be a potential candidate for cancer therapeutics. Through present review, we aim to provide insights into sporulation, transmission and pathogenesis of B. anthracis as well as the current state of its prevention, treatment, vaccines and possible therapeutic uses in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthraxBacillus anthracisAnthrax VaccinesHumansAnimalsBacterial ToxinsSpores, BacterialAntigens, Bacterial

Stichwörter der Autor:innen

anthrax vaccinebacterial toxingerminationpathogenesissporulation

Substanzen

Bacterial Toxinsanthrax toxinAnthrax VaccinesAntigens, Bacterial

Autor:innen und Institutionen

  • Department of Biomedical Science, Bhaskaracharya College of Applied Sciences, University of Delhi, Delhi 110075, India.
  • Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA 94305, USA.
  • Dr. B.R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110007, India.
  • Department of Biochemistry, Shivaji College, University of Delhi, Delhi 110027, India.

ORCID-Profile: Uma Dhawan, Renu Baweja, Yogendra Singh

Zitieren

APA

Sangwan, N., Gangwal, A., Jain, P., Langtso, C., Srivastava, S., Dhawan, U., Baweja, R., & Singh, Y. (2025). Anthrax: Transmission, Pathogenesis, Prevention and Treatment. Toxins, 17(2), 56. https://doi.org/10.3390/toxins17020056

Vancouver

Sangwan N, Gangwal A, Jain P, Langtso C, Srivastava S, Dhawan U, et al. Anthrax: Transmission, Pathogenesis, Prevention and Treatment. Toxins. 2025;17(2):56. doi:10.3390/toxins17020056

BibTeX
@article{Sangwan2025,
  author = {Sangwan, Nitika and Gangwal, Aakriti and Jain, Preksha and Langtso, Chokey and Srivastava, Shruti and Dhawan, Uma and Baweja, Renu and Singh, Yogendra},
  title = {Anthrax: Transmission, Pathogenesis, Prevention and Treatment},
  journal = {Toxins},
  year = {2025},
  volume = {17},
  number = {2},
  pages = {56},
  doi = {10.3390/toxins17020056}
}
Kostenlos starten →